Abstract:BackgroundLarge-scale genetic screening using CRISPR-Cas9 technology has emerged as a powerful approach to uncover and validate gene functions. The ability to control the timing of genetic perturbation during CRISPR screens will facilitate precise dissection of dynamic and complex biological processes. Here, we report the optimization of a drug-inducible CRISPR-Cas9 system that allows high-throughput gene interrogation with a temporal control.ResultsWe designed multiple drug-inducible sgRNA expression vectors and measured their activities using an EGFP gene disruption assay in 11 human and mouse cell lines. The optimal design allows for a tight and inducible control of gene knockout in vitro, and in vivo during a seven-week-long experiment following hematopoietic reconstitution in mice. We next performed parallel genome-wide loss-of-function screens using the inducible and constitutive CRISPR-Cas9 systems. In proliferation-based dropout screens, these two approaches have similar performance in discriminating essential and nonessential genes. In a more challenging phenotypic assay that requires cytokine stimulation and cell staining, we observed similar sensitivity of the constitutive and drug-induced screening approaches in detecting known hits. Importantly, we demonstrate minimal leakiness of our inducible CRISPR screening platforms in the absence of chemical inducers in large-scale settings.ConclusionsIn this study, we have developed a drug-inducible CRISPR-Cas9 system that shows high cleavage efficiency upon induction but low background activity. Using this system, we have achieved inducible gene disruption in a wide range of cell types both in vitro and in vivo. For the first time, we present a systematic side-by-side comparison of constitutive and drug-inducible CRISPR-Cas9 platforms in large-scale functional screens. We demonstrate the tightness and efficiency of our drug-inducible CRISPR-Cas9 system in genome-wide pooled screening. Our design increases the versatility of CRISPR-based genetic screening and represents a significant upgrade on existing functional genomics toolbox.

A high-content flow cytometry and dual CRISPR-Cas9 based platform to quantify genetic interactions

Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform

Genetic interaction library screening with a next-generation dual guide CRISPR system

High-content CRISPR screening

CRISPR gene and transcriptome engineering (CRISPRgate) improves loss-of-function genetic screening approaches

A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens

[High-throughput functional screening using CRISPR/Cas9 system].

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations

Linking Genotypes with Multiple Phenotypes in Single-Cell CRISPR Screens

High-content imaging-based pooled CRISPR screens in mammalian cells

Pooled Genome-Scale CRISPR Screens in Single Cells

Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing

Discovery of Zika Virus Dependency and Restriction Factors Using Flow-Based Arrayed CRISPR Screening for Identification of Targets (FACS-IT)

Optimal methods for analyzing targeted pairwise knockout screens

High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening

Arrayed CRISPR/Cas9 Screening for the Functional Validation of Cancer Genetic Dependencies